To the Editor:
Birth cohort studies have yielded important information regarding sensitization profiles in early life and their associations with the development of subsequent allergic disease. The design of these cohorts differs, and these differences are critical to interpretation of the data. Higher rates of sensitization have been established in high-risk cohorts of children who have a family history of allergies and asthma compared with unselected population cohorts. Indeed, the rate of sensitization in children aged 1 year in the high-risk Cincinnati Childhood Air Pollution Study (CCAAPS) was 28% compared with just 8% reported in children aged 1.5 years in unselected birth cohorts. 1 Epidemiologic studies consistently show an association between atopy and asthma. Atopic dermatitis (AD) is an established risk factor for asthma development, and it has been estimated that one-third to onehalf of patients with AD will develop asthma. 2 However, the sensitization rates and profiles in a cohort of children with AD are not established. We sought to compare the sensitization rates and profiles of children in the CCAAPS cohort, a high-risk asthma cohort based on parental atopy, and the Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH) cohort, a high-risk asthma cohort based on the presence of AD.
The MPAACH cohort is the first US-based, prospective, earlylife cohort of children with AD and the first mechanistic cohort of children with AD designed to elucidate endotypes of AD that progress to asthma and identify biomarkers of disease progression. The inclusion criteria were (1) age of < _2 years at enrollment, (2) gestation of at least 36 weeks, and (3) a diagnosis of AD (based on the Hanifin and Rajka criteria for AD 3 ), or the parent(s) or legal authorized representative indicates a positive response to each of the 3 questions from the Children's Eczema Questionnaire. 4 The CCAAPS cohort is a high-risk birth cohort of infants with at least 1 atopic parent, defined as a parent with symptoms of allergy and/ or asthma diagnosis and a positive skin prick test (SPT) to at least 1 aeroallergen. 5 The CCAAPS inclusion criteria also included a gestational age of at least 35 weeks. In CCAAPS, the definition of AD was adapted from a validated questionnaire (International Study of Asthma and Allergies in Childhood) and included a parental report of the child's scratching and redness, ''raised bumps,'' or dry skin and/or scaling for at least 6 of the last 12 months. 6 Participants in both cohorts had SPTs to aeroallergens and food allergens performed as part of the study protocol. Herein we have compared the SPT results at the age of 1 year in both cohorts, as age may affect sensitization rates. The CCAAPS cohort was skintested to a panel of 15 aeroallergens, milk, and egg, as previously reported. 5 SPTs in the MPAACH cohort include 11 aeroallergens and 13 food allergens. In this analysis, we directly compared rates of sensitization to dog, mold, tree, cat, grass, dust mite, ragweed, egg and milk; the comparisons were performed by using the same method in both cohorts. Sensitization patterns in the MPAACH cohort (N 5 128) were compared with the patterns in the overall CCAAPS cohort (N 5 712), the subset with AD (n 5 222), and those subset of those without AD (n 5 490). All data and sensitization results were analyzed via chi-square and/or Fisher exact tests using SAS software (SAS Institute, Inc, Cary, NC).
Demographic comparisons highlight the distinct recruitment techniques and populations of each high-risk cohort. MPAACH recruitment is conducted at an urban hospital; the cohort comprises 53% black participants and 54% participants with public insurance. In contrast, the CCAAPS cohort is a populationbased cohort and includes 21% black participants (P < .01) and 24% with public insurance (P < .01).
When compared with the CCAAPS cohort, the MPAACH children were significantly more likely to be sensitized to any allergen (42.2% versus 28.8%; P 5 .003), cosensitized to both food and aeroallergens (14.8% versus 4.2%; P 5 .009), sensitized to food allergens only (28.1% versus 14.2%; P < .001), and sensitized to aeroallergens only (28.9% versus 18.8%; P 5 .009; Fig 1,  A) . At the individual allergen level, the MPAACH children were also significantly more likely to be sensitized to dog (11.7% versus 1.4%; P < .001), cockroach (5.5% versus 2.0%; P 5 .029), and egg (26.6% versus 12.3%; P 5 .001, Fig 1, B) , highlighting the fact that children with AD are at much higher risk for developing atopy than are children in a high-risk asthma cohort based on parental atopy.
To determine whether AD was indeed driving the higher sensitization rates in the MPAACH cohort, we compared sensitization rates in children with AD in the CCAAPS with those of children in the CCAAPS without AD. As in the MPAACH cohort, the subgroup of the CCAAPS cohort with AD had higher rates of sensitization to any allergen (43.2% versus 22.2%; P < .001), cosensitization (9.0% versus 2.0%; P < .001), sensitization to food only (25.3% versus 9.2%; P < .001), and sensitization to aeroallergens only (27.0% versus 15.1%; P < .001, Fig 1, A) compared with the group without AD. The group with AD had higher rates of sensitization to trees (10.4% versus 5.3%; P 5 .014), cats (6.3% versus 1.9%; P < .001), egg (22.6% versus 7.6%; P < .001), and milk (7.7% versus 2.7%; P 5 .002, Fig 1, B) . The rate of dog sensitization was also higher in the group with AD (2.7% versus 0.8%; P 5 .048); however, it was significantly lower than the prevalence in the MPAACH cohort (11.7%; P 5 .001; Fig 1, B) .
Herein we have shown that the rate of sensitization in the cohort with pediatric AD is almost 1.5-fold higher than the rate for a high-risk asthma and allergy cohort, even though the rate of parental history of allergic disease was highly comparable. These results suggest that AD further increases the risk of sensitization over heredity alone. Children from the MPAACH study and children with AD from the CCAAPS are almost twice as likely to be sensitized to any allergens and almost 4 times more likely to be cosensitized to food and aeroallergens. Both cohorts had increased sensitization rates when compared with the general population. 7 The MPAACH children and the CCAAPS children with AD had similar sensitization profiles despite stark demographic differences, supporting the idea that AD independently contributes to increased sensitization risk. Although it has been reported that children with AD may develop peanut and egg sensitizations through epidermal allergen exposure, 8, 9 our findings suggest cutaneous sensitization of aeroallergens as well. Future analyses of sensitization patterns in the MPAACH cohort will determine which phenotypes of AD are associated with early persistent, early transient, and late transient sensitization in children and will ultimately establish which AD phenotypes and sensitization profiles are most predictive of asthma and clinical allergy development in children.
